Autonomix Medical (NASDAQ:AMIX) Announces Quarterly Earnings Results, Beats Expectations By $1.38 EPS

Autonomix Medical (NASDAQ:AMIX) released its quarterly earnings data on Wednesday. The company reported ($5.02) earnings per share for the quarter, beating analysts’ consensus estimates of ($6.40) by $1.38, FiscalAI reports.

Autonomix Medical Stock Down 7.5%

NASDAQ:AMIX traded down $0.56 during trading hours on Thursday, hitting $6.96. 260,780 shares of the stock traded hands, compared to its average volume of 1,562,546. Autonomix Medical has a 1 year low of $2.44 and a 1 year high of $32.55. The company has a market cap of $6.76 million, a price-to-earnings ratio of -0.09 and a beta of -1.17. The stock has a 50 day moving average price of $6.86 and a 200 day moving average price of $7.76.

Analyst Ratings Changes

AMIX has been the topic of several analyst reports. Weiss Ratings upgraded shares of Autonomix Medical from a “sell (e)” rating to a “sell (e+)” rating in a research note on Tuesday, July 28th. Zacks Research raised shares of Autonomix Medical to a “hold” rating in a research report on Tuesday, June 2nd. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $42.00.

Autonomix Medical Company Profile

Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.